JANE STREET GROUP, LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 108 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 4.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$25,989
-69.8%
24,064
-63.9%
0.00%
Q2 2023$85,924
-49.5%
66,608
-48.4%
0.00%
Q1 2023$170,284
+7.6%
129,003
+22.3%
0.00%
Q4 2022$158,200
-44.7%
105,467
-56.5%
0.00%
Q3 2022$286,000
+253.1%
242,544
+237.6%
0.00%
Q2 2022$81,000
-53.2%
71,853
+23.9%
0.00%
Q1 2022$173,000
-45.9%
58,016
-52.0%
0.00%
Q4 2021$320,000
-73.2%
120,850
-63.2%
0.00%
Q3 2021$1,192,000
+34.1%
328,429
+60.3%
0.00%
Q2 2021$889,000
+1678.0%
204,934
+1310.5%
0.00%
Q1 2021$50,000
-72.1%
14,529
-71.6%
0.00%
Q4 2020$179,000
+141.9%
51,166
+65.3%
0.00%
Q3 2020$74,000
-58.0%
30,953
-67.8%
0.00%
Q2 2020$176,000
-12.9%
95,990
+23.8%
0.00%
Q2 2019$202,000
+494.1%
77,560
+491.2%
0.00%
Q1 2019$34,000
-76.6%
13,120
-64.9%
0.00%
Q4 2017$145,000
+126.6%
37,418
+49.4%
0.00%
Q3 2017$64,000
+60.0%
25,045
+131.6%
0.00%
Q3 2016$40,000
-65.8%
10,816
-66.9%
0.00%
-100.0%
Q1 2015$117,000
+28.6%
32,661
-30.7%
0.00%0.0%
Q3 2014$91,00047,1250.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
CM Management, LLC 1,500,000$1,620,0001.72%
Soleus Capital Management, L.P. 14,803,015$15,987,2561.48%
ARMISTICE CAPITAL, LLC 17,136,000$18,506,8800.28%
SPHERA FUNDS MANAGEMENT LTD. 1,228,126$1,326,3760.24%
GSA CAPITAL PARTNERS LLP 971,441$1,0490.09%
NJ State Employees Deferred Compensation Plan 200,000$216,0000.03%
Providence Wealth Advisors, LLC 27,500$29,0130.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,151,765$1,243,9060.03%
XTX Topco Ltd 164,238$177,3770.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 3,369,076$3,638,6020.02%
View complete list of RIGEL PHARMACEUTICALS INC shareholders